Hyperfine Inc (HYPR) Noticias

Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets

Strategic agreements set the stage for further global adoption of portable MR brain imaging technology...

Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care

Eleven clinical studies presented at RSNA 2024 highlighted the growing clinician experience with the Swoop®...

Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals

Two new executive roles position Hyperfine to drive the adoption of the Swoop® system in hospital settings and...

Hyperfine Swoop® Portable MR Brain Imaging System Meets New Standards Recently Issued by CMS-Approved Accrediting Body

Intersocietal Accreditation Commission (IAC)’s release of new standards accepting ultra-low-field MRI...

Hyperfine Announces Ten Abstracts at RSNA, Highlighting the Expanding Utility and Potential of Portable MR Brain Imaging in Diverse Clinical and Research Settings

The breadth of data being presented at the premier radiology meeting of 2024 illustrates the increasing...

Form 4 - Statement of changes in beneficial ownership of securities

Hyperfine, Inc. to Participate in Upcoming Investor Conferences

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Hyperfine, Inc. Reports Third Quarter 2024 Financial Results

GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking...

Hyperfine Announces European Launch with CE Approval

CE approval of the latest generation Swoop® system software is a significant milestone in Hyperfine’s...

Hyperfine Announces Alzheimer’s Research with Promising Swoop® System Data and Advanced Image Quality

Today’s presentation at CTAD, a leading international Alzheimer's conference, expands research supporting the...

Hyperfine, Inc. to Announce Third Quarter 2024 Financial Results on November 12, 2024

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable...

Hyperfine Swoop® Portable MR Imaging® System Utilized in Multicenter SAFE MRI ECMO Study Published in the September 29th Issue of Circulation

The SAFE MRI ECMO study evaluated the use of ultra-low-field portable MR imaging on ICU patients undergoing...

Hyperfine Announces Promising Interim Findings on the Value of Portable, Ultra-low-field MR Imaging for Acute Stroke Care

The Swoop® Portable MR Imaging® system shows faster time-to-scan compared to conventional MRI and good specificity in emergency stroke...